Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)

This study has been completed.
Sponsor:
Collaborator:
Enzon Pharmaceuticals, Inc.
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00177684
First received: September 13, 2005
Last updated: December 16, 2008
Last verified: December 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given
No publications provided by University of Pittsburgh

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):